Summary
We studied the effect of the ras oncogene on the growth kinetics, morphology, cytoskeletal structure, and tumorigenicity of the widely used NRK-52E rat kidney epithelial cell line and two H-ras oncogene-transformed cell lines, H/1.2-NRK-52E (H/1.2) and H/6.1-NRK-52E (H/6.1). Population doubling times of NRK-52E, H/1.2, and H/6.1 cells were 28, 26, and 24 h, respectively, with the transformed cells reaching higher saturation densities than the parent cells. NRK-52E cells had typical epithelial morphology with growth in colonies. H/1.2 and H/6.1 cell colonies were more closely packed, highly condensed, and had increased plasma membrane ruffling compared to parent cell colonies. NRK-52E cells showed microfilament, microtubule, and intermediate filament networks typical of epithelial cells, while H/1.2 and H/6.1 cells showed altered cytoskeleton architecture, with decreased stress fibers and increased microtubule and intermediate filament staining at the microtubule organizing center. H/1.2 and H/6.1 cells proliferated in an in vitro soft agar transformation assay, indicating anchorage-independence, and rapidly formed tumors in vivo with characteristics of renal cell carcinoma, including mixed populations of sarcomatoid, granular, and clear cells, H/6.1 cells consistently showed more extensive alterations of growth kinetics, morphology, and cytoskeleton than H/1.2 cells, and formed tumors of a more aggressive phenotype. These data suggest that analysis of renal cell characteristics in vitro may have potential in predicting tumor behavior in vivo, and significantly contribute to the utility of these cell lines as in vitro models for examining renal epithelial cell biology and the role of the ras proto-oncogene in signal transduction involving the cytoskeleton.
Similar content being viewed by others
References
Andries, M.; Tilemans, D.; Denef, C. Modulation of epidermal growth factor receptor binding and action by N-acetyl-TGFα(34–43) methyl ester. Peptides 15:619–625; 1994.
Anzano, M. A.; Rieman, D.; Prichett, W., et al. Growth factor production by human colon carcinoma cell lines. Cancer Res. 49:2898–2904; 1989.
Baghdassarian, D.; Toru-Delbauffe, D.; Gavaret, J.-M., et al. Effects of transforming growth factor-β1 on the extracellular matrix and cytoskeleton of cultured astrocytes. Glia 7:193–202; 1993.
Bar-Sagi, D.; Feramisco, J. R. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science (Wash., DC) 233:1061–1068; 1986.
Basolo, F.; Elliott, J.; Tait, L., et al. Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol. Carcinog. 4:25–35; 1991.
Bos, J. B. ras oncogenes in human cancer: a review. Cancer Res. 49:4682–4689; 1989.
Burns, J. S.; Blaydes, J. P.; Wright, P. A., et al. Stepwise transformation of primary thyroid epithelial cells by a mutant Ha-ras oncogene: an in vitro model of tumor progression. Mol. Carcinog. 6:129–139; 1992.
Chou, Y.-H.; Skalli, O.; Goldman, R. D. Intermediate filaments and cytoplasmic networking: new connections and more functions. Curr. Opin. Cell Biol. 9:49–53; 1997.
Dartsch, P. C.; Ritter, M.; Häussinger, D., et al. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene. Eur. J. Cell Biol. 63:316–325; 1994.
Davis, M. A.; Chang, S. H.; Trump, B. F. Differential sensitivity of normal and H-ras oncogene-transformed rat kidney epithelial cells to okadaic acid-induced apoptosis. Toxicol. Appl. Pharmacol. 141:93–101; 1996.
Davis, M. A.; Smith, M. W.; Chang, S. H., et al. Characterization of a renal epithelial cell model of apoptosis using okadaic acid and the NRK-52E cell line. Toxicol. Pathol. 22:595–605; 1994.
DeLarco, J. E.; Todaro, G. J. Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation. J. Cell Physiol. 94:335–342; 1978.
Duc-Nguyen, H.; Rosenblum, E. N.; Zeigel, R. F. Persistent infection of a rat kidney cell line with a Rauscher murine leukemia virus. J. Bacteriol. 92:1133–1139; 1966.
Durkin, J. P.; Whitfield, J. F. Characterization of the mitogenic signal from an oncogene ras protein. Anticancer Res. 9:1313–1324; 1991.
Franch, H. A.; Shay, J. W.; Alpern, R. J., et al. Involvement of the pRB family in TGFβ-dependent epithelial cell hypertrophy. J. Cell Biol. 129:245–254; 1995.
Fukuishi, N.; Gemba, M. Use of cultured renal epithelial cells for the study of cisplatin toxicity. Jpn. J. Pharmacol. 50:247–249; 1989.
Garbi, C.; Colletta, G.; Cirafici, A. M., et al. Transforming growth factor-β induces cytoskeleton and extracellular matrix modifications in FRTL-5 thyroid epithelial cells. Eur. J. Cell Biol. 53:281–289; 1990.
Geuens, G.; de Brabander, M.; Nuydens, R., et al. The interaction between microtubules and intermediate filaments in cultured cells treated with taxol and nocodazole. Cell Biol. Int. Rep. 7:35–47; 1983.
Hartmann, G.; Weidner, K. M.; Schwarz, H., et al. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras. J. Biol. Chem. 269:21936–21939; 1994.
Haugen, A.; Ryberg, D.; Hansteen, I., et al. Neoplastic transformation of a human kidney epithelial cell line transfected with v-Ha-ras oncogene. Int. J. Cancer 45:572–577; 1990.
Hise, M. K.; Jacobs, S. C.; Papadimitriou, J. C., et al. Transforming growth factor-α expression in human renal cell carcinoma. Urology 47:29–33; 1996.
Hordijk, P. L.; ten Klooster, J. P.; vander Kammen, R. A., et al. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science (Wash., DC) 278:1464–1466; 1997.
Hotchin, N. A.; Hall, A. The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases. J. Cell Biol. 131:1857–1865; 1995.
Houck, K. A.; Michalopoulos, G. K.; Strom, S. C. Introduction of Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-β. Oncogene 4:19–25; 1989.
Huber, L. A.; Pasquali, C.; Gagescu, R., et al. Endosomal fractions from viral K-ras-transformed MDCK cells reveal transformation specific changes on two-dimensional gel maps. Electrophoresis 17:1734–1740; 1996.
Hugenschmidt, S.; Planas-Bohne, F.; Taylor, D. M. On the toxicity of low doses of tetrasodium-ethylenediamine-tetraacetate (Na-EDTA) in normal rat kidney (NRK) cells in culture. Arch. Toxicol. 67:76–78; 1993.
Humes, H. D.; Nakamura, T.; Cieslinski, D. A., et al. Role of proteoglycans and cytoskeleton in the effects of TGF-β1 on renal proximal tubule cells. Kidney Int. 43:575–584; 1993.
Hunter, T. Oncoprotein networks. Cell 88:333–346; 1997.
Hyman, A. A.; Karsenti, E. Morphogenetic properties of microtubules and mitotic spindle assembly. Cell 84:401–410; 1996.
Joneson, T.; White, M. A.; Wigler, M. H., et al. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of Ras. Science 271:810–812; 1996.
Kerr, D. I.; Plumb, J. A.; Freshney, R. I., et al. The effect of H-ras oncogene transfection on response on mink lung epithelial cells to growth factors and cytotoxic drugs. Anticancer Res. 11:1349–1352; 1991.
Khosravi-Far, R.; Der, C. J. The Ras signal transduction pathway. Cancer Metastasis Rev. 13:67–89; 1994.
Konishi, N.; Donovon, P. J.; Ward, J. M. Differential effects of renal carcinogens and tumor promoters on growth promotion and inhibition of gap junctional communication in two rat epithelial cell lines. Carcinogenesis 11:903–908; 1990.
Lim, L. C.; Segal, G. H.; Wittwer, C. T. Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalin-fixed, paraffin-embedded tissues. Am. J. Clin. Pathol. 104:689–695; 1995.
Maniotis, A. J.; Chen, C. S.; Ingber, D. E. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilzie nuclear structure. Proc. Natl. Acad. Sci. USA 94:849–854; 1997.
McCormick, F. Activators and effectors of ras p21 proteins. Curr. Opin. Genet. Dev. 4:71–76; 1994.
Mulder, K. M.; Morris, S. L. Activation of p21ras by transforming growth factor β in epithelial cells. J. Biol. Chem. 267:5029–5031; 1992.
Ochiai, H.; Ikesue, A.; Kurokawa, M., et al. Enhanced production of rat interleukin-8 by in vitro and in vivo infections with influenza A NWS virus. J. Virol. 67:6811–6814; 1993.
Ohgaki, H.; Kleihues, P.; Hard, G. C. Ki-ras mutations in spontaneous and chemically induced renal tumors of the rat. Mol. Carcinog. 4:455–459; 1991.
Ohnishi, Y.; Nakamura, H.; Yoshimura, M., et al. Prolonged survival of mice with human gastric cancer treated with an anti-c-erbB-2 monoclonal antibody. Br. J. Cancer 71:969–973; 1995.
Phelps, P. C.; Best, C. J. M.; Berezesky, I. K., et al. Studies on the mechanism of sulofenur and LY295501 toxicity: effect on the regulation of cytosolic calcium in relation to cytotoxicity in normal and tumorigenic rat kidney cell lines. Cancer Lett. 97:7–15; 1995.
Prendergast, G. C.; Gibbs, J.B. Pathways of Ras function: connections to the actin cytoskeleton. Adv. Cancer Res. 62:19–64; 1993.
Qiu, R.-G.; Chen, J.; Kirn, D., et al. An essential role for Rac in Ras transformation. Nature (Lond.) 374:457–459; 1995.
Qiu, R.-G.; Chen, J.; McCormick, F., et al. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA 92:11781–11785; 1995.
Rak, J.; Mitsuhashi, Y.; Bayko, L., et al. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55:4575–4580; 1995.
Ridley, A.; Comoglio, P. M.; Hall, A. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol. Cell. Biol. 15:1110–1122; 1995.
Ridley, A. J.; Paterson, H. F.; Johnston, C. L., et al. The small GTP-binding protein Rac regulates growth factor-induced membrane ruffling. Cell 70:401–410; 1992.
Schäfer, R. Suppression of ras oncogene-mediated transformation. Rev. Physiol. Biochem. Pharmacol. 124:30–91; 1994.
Sistonen, L.; Keski-Oja, J.; Ulmanen, I., et al. Dose effects of transfected c-Ha-ras Val12 oncogene in transformed cell clones. Exp. Cell Res. 168:518–530; 1987.
Slebos, R. J. C.; Rodenhuis, S. The ras gene family in human non-small-cell lung cancer. J. Natl. Cancer Inst. 13:23–29; 1992.
Spandidos, D. A. Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature (Lond.) 310:469–475; 1984.
Stewart, P. M.; Whorwood, C. B. 11-β-Hydroxysteroid dehydrogenase activity and corticosteroid hormone action. Steroids 59:90–95; 1994.
Stromskaya, T. P.; Grigorian, I. A.; Ossovskaya, V. S., et al. Cell-specific effects of ras oncogene and protein kinase C agonist TPA on P-glycoprotein function. FEBS Lett. 368:373–376; 1995.
Walker, C.; Everitt, J.; Freed, J. J., et al. Altered expression of transforming growth factor-β in hereditary rat renal carcinoma. Cancer Res. 51:2973–2978; 1991.
Watanabe, K.; Kinoshita, S.; Nakagawa, H. Purification and characterization of cytokine-induced neutrophil chemoattractant produced by an epithelioid cell line of normal rat kidney (NRK-52E). Biochem. Biophys. Res. Comm. 161:1093–1099; 1989.
Yan, Z.; Winawer, S.; Friedman, E. Two different signal transduction pathways can be activated by transforming growth factor β1 in epithelial cells. J. Biol. Chem. 269:13231–13237; 1994.
Yoakum, G. H.; Lechner, J. F.; Gabrielson, E. W., et al. Transformation of human bronchial epithelial cells transfected by Harvey ras oncogene. Science 227:1174–1179; 1985.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Best, C.J.M., Tanzer, L.R., Phelps, P.C. et al. H-ras-transformed NRK-52E renal epithelial cells have altered growth, morphology, and cytoskeletal structure that correlates with renal cell carcinoma in vivo . In Vitro Cell.Dev.Biol.-Animal 35, 205–214 (1999). https://doi.org/10.1007/s11626-999-0028-2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11626-999-0028-2